$17.37
▲ +$0.30
(+1.76%)
Vol 380K
Wall Street Consensus
11 analysts · Apr 20264
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
90.9%
Buy Rating
Price Chart
Similar Stocks
KALV
Kalvista Pharmaceuticals Inc
$816.3M
CTMX
CytomX Therapeutics Inc
P/E 25.8
$721.8M
CMPX
Compass Therapeutics Inc.
$955.1M
CDNA
CareDx Inc
P/E 15.9
$969.0M
INBX
Inhibrx Biosciences Inc
$1.1B
JANX
Janux Therapeutics Inc
$830.0M
MPLT
MapLight Therapeutics Inc
$797.0M
ORIC
Oric Pharmaceuticals Inc
$796.6M
Quarterly Revenue & Earnings
| Quarter | 2024-1… |
|---|---|
| Revenue | $933K |
| Net Income | -$12.1M |
Financial Health
Free Cash Flow
-$15.0M
Net Debt
-$168.4M
Cash
$180.3M
Total Debt
$11.9M
As of Sep 30, 2025
Peer Comparison
| Ticker | Mkt Cap | P/E | P/S | ROE | Margin | Beta |
|---|---|---|---|---|---|---|
| AKTS | — | — | — | — | — | — |
| KALV | $816.3M | — | 54.0 | -237.5% | -724.8% | -0.15 |
| CTMX | $721.8M | 25.8 | 6.4 | 10.9% | 24.7% | 2.48 |
| CMPX | $955.1M | — | — | -34.5% | — | 1.29 |
| CDNA | $969.0M | 15.9 | 2.7 | 17.4% | 17.0% | 2.54 |
| INBX | $1.1B | — | 820.7 | -140.3% | -5465.6% | 2.35 |
| JANX | $830.0M | — | 83.0 | -10.2% | -243.1% | 2.85 |
| MPLT | $797.0M | — | — | — | — | -0.56 |
Latest News
No related news yet